External Validation of the Bone Metastases Ensemble Trees for Survival (BMETS) Machine Learning Model to Predict Survival in Patients With Symptomatic Bone Metastases

The Bone Metastases Ensemble Trees for Survival (BMETS) model uses a machine learning algorithm to estimate survival time following consultation for palliative radiation therapy for symptomatic bone metastases (SBM). BMETS was developed at a tertiary-care, academic medical center, but its validity a...

Full description

Saved in:
Bibliographic Details
Published inJCO clinical cancer informatics Vol. 5; p. 304
Main Authors Elledge, Christen R, LaVigne, Anna W, Fiksel, Jacob, Wright, Jean L, McNutt, Todd, Kleinberg, Lawrence R, Hu, Chen, Smith, Thomas J, Zeger, Scott, DeWeese, Theodore L, Alcorn, Sara R
Format Journal Article
LanguageEnglish
Published United States 01.03.2021
Subjects
Online AccessGet more information

Cover

Loading…
Abstract The Bone Metastases Ensemble Trees for Survival (BMETS) model uses a machine learning algorithm to estimate survival time following consultation for palliative radiation therapy for symptomatic bone metastases (SBM). BMETS was developed at a tertiary-care, academic medical center, but its validity and stability when applied to external data sets are unknown. Patients treated with palliative radiation therapy for SBM from May 2013 to May 2016 at two hospital-based community radiation oncology clinics were included, and medical records were retrospectively reviewed to collect model covariates and survival time. The Kaplan-Meier method was used to estimate overall survival from consultation to death or last follow-up. Model discrimination was estimated using time-dependent area under the curve (tAUC), which was calculated using survival predictions from BMETS based on the initial training data set. A total of 216 sites of SBM were treated in 182 patients. Most common histologies were breast (27%), lung (23%), and prostate (23%). Compared with the BMETS training set, the external validation population was older (mean age, 67 62 years; < .001), had more primary breast (27% 19%; = .03) and prostate cancer (20% 12%; = .01), and survived longer (median, 10.7 6.4 months). When the BMETS model was applied to the external data set, tAUC values at 3, 6, and 12 months were 0.82, 0.77, and 0.77, respectively. When refit with data from the combined training and external validation sets, tAUC remained 0.79. BMETS maintained high discriminative ability when applied to an external validation set and when refit with new data, supporting its generalizability, stability, and the feasibility of dynamic modeling.
AbstractList The Bone Metastases Ensemble Trees for Survival (BMETS) model uses a machine learning algorithm to estimate survival time following consultation for palliative radiation therapy for symptomatic bone metastases (SBM). BMETS was developed at a tertiary-care, academic medical center, but its validity and stability when applied to external data sets are unknown. Patients treated with palliative radiation therapy for SBM from May 2013 to May 2016 at two hospital-based community radiation oncology clinics were included, and medical records were retrospectively reviewed to collect model covariates and survival time. The Kaplan-Meier method was used to estimate overall survival from consultation to death or last follow-up. Model discrimination was estimated using time-dependent area under the curve (tAUC), which was calculated using survival predictions from BMETS based on the initial training data set. A total of 216 sites of SBM were treated in 182 patients. Most common histologies were breast (27%), lung (23%), and prostate (23%). Compared with the BMETS training set, the external validation population was older (mean age, 67 62 years; < .001), had more primary breast (27% 19%; = .03) and prostate cancer (20% 12%; = .01), and survived longer (median, 10.7 6.4 months). When the BMETS model was applied to the external data set, tAUC values at 3, 6, and 12 months were 0.82, 0.77, and 0.77, respectively. When refit with data from the combined training and external validation sets, tAUC remained 0.79. BMETS maintained high discriminative ability when applied to an external validation set and when refit with new data, supporting its generalizability, stability, and the feasibility of dynamic modeling.
Author Smith, Thomas J
DeWeese, Theodore L
LaVigne, Anna W
Elledge, Christen R
Fiksel, Jacob
Kleinberg, Lawrence R
Hu, Chen
Zeger, Scott
Wright, Jean L
McNutt, Todd
Alcorn, Sara R
Author_xml – sequence: 1
  givenname: Christen R
  orcidid: 0000-0002-6047-3219
  surname: Elledge
  fullname: Elledge, Christen R
  organization: Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD
– sequence: 2
  givenname: Anna W
  orcidid: 0000-0001-6872-9357
  surname: LaVigne
  fullname: LaVigne, Anna W
  organization: Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD
– sequence: 3
  givenname: Jacob
  orcidid: 0000-0001-7067-1334
  surname: Fiksel
  fullname: Fiksel, Jacob
  organization: Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
– sequence: 4
  givenname: Jean L
  surname: Wright
  fullname: Wright, Jean L
  organization: Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD
– sequence: 5
  givenname: Todd
  surname: McNutt
  fullname: McNutt, Todd
  organization: Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD
– sequence: 6
  givenname: Lawrence R
  orcidid: 0000-0003-2473-2305
  surname: Kleinberg
  fullname: Kleinberg, Lawrence R
  organization: Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD
– sequence: 7
  givenname: Chen
  orcidid: 0000-0003-4672-1981
  surname: Hu
  fullname: Hu, Chen
  organization: Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD
– sequence: 8
  givenname: Thomas J
  orcidid: 0000-0003-3040-6434
  surname: Smith
  fullname: Smith, Thomas J
  organization: Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD
– sequence: 9
  givenname: Scott
  orcidid: 0000-0001-8907-1603
  surname: Zeger
  fullname: Zeger, Scott
  organization: Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
– sequence: 10
  givenname: Theodore L
  surname: DeWeese
  fullname: DeWeese, Theodore L
  organization: Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD
– sequence: 11
  givenname: Sara R
  orcidid: 0000-0003-4620-5047
  surname: Alcorn
  fullname: Alcorn, Sara R
  organization: Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33760638$$D View this record in MEDLINE/PubMed
BookMark eNpdkFFLwzAUhYMobs69-Sx51IfONO2a9FFL1cGKg019HGly6yJtOpJsuD_k7zSgIggXLvfAdw73nKFj0xtA6CImk5gSclMUswklE0Jiyo_QkKYsiVLKsgEaO_dOgs7TNEvzUzRIEpaRLOFD9Fl-eLBGtPhFtFoJr3uD-wb7DeC74I8r8MKFAYdL46CrW8ArC-FseouXO7vX-0Bf3VXlanmNKyE3OmBzENZo84arXkGLfY8XFpSW_g_RBi9CHhjv8Kv2G7w8dFvfd0GT_7PP0UkjWgfjnz1Cz_flqniM5k8Ps-J2Hkmaxz4KbzEGFBLJmIynYppzlUDMKM1Iw5Na1TWXjeSEq0zxaZrnQONQSS5VTWsl6Qhdfvtud3UHar21uhP2sP4tjH4BYt1vVw
CitedBy_id crossref_primary_10_1016_j_semradonc_2022_11_002
crossref_primary_10_1111_jep_13652
crossref_primary_10_3390_cancers15051596
crossref_primary_10_1016_j_semradonc_2023_01_003
crossref_primary_10_1097_SPC_0000000000000645
crossref_primary_10_1200_CCI_22_00082
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1200/CCI.20.00128
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
EISSN 2473-4276
ExternalDocumentID 33760638
Genre Journal Article
GroupedDBID 0R~
53G
ABDBF
ALMA_UNASSIGNED_HOLDINGS
C45
CGR
CUY
CVF
DIWNM
EBS
ECM
EIF
FBNNL
H13
NPM
O9-
OVD
RLZ
RUC
TEORI
ID FETCH-LOGICAL-c291t-37677e2e3c77c15a598d3e172260f83bdbb8cfc808d6d85499e216499cdb2bdc2
IngestDate Tue Aug 27 13:49:08 EDT 2024
IsPeerReviewed true
IsScholarly true
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c291t-37677e2e3c77c15a598d3e172260f83bdbb8cfc808d6d85499e216499cdb2bdc2
ORCID 0000-0002-6047-3219
0000-0001-7067-1334
0000-0001-8907-1603
0000-0001-6872-9357
0000-0003-4672-1981
0000-0003-4620-5047
0000-0003-3040-6434
0000-0003-2473-2305
PMID 33760638
ParticipantIDs pubmed_primary_33760638
PublicationCentury 2000
PublicationDate 2021-03-00
PublicationDateYYYYMMDD 2021-03-01
PublicationDate_xml – month: 03
  year: 2021
  text: 2021-03-00
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle JCO clinical cancer informatics
PublicationTitleAlternate JCO Clin Cancer Inform
PublicationYear 2021
SSID ssj0001844649
Score 2.2469983
Snippet The Bone Metastases Ensemble Trees for Survival (BMETS) model uses a machine learning algorithm to estimate survival time following consultation for palliative...
SourceID pubmed
SourceType Index Database
StartPage 304
SubjectTerms Aged
Bone Neoplasms - mortality
Humans
Machine Learning
Palliative Care
Retrospective Studies
Title External Validation of the Bone Metastases Ensemble Trees for Survival (BMETS) Machine Learning Model to Predict Survival in Patients With Symptomatic Bone Metastases
URI https://www.ncbi.nlm.nih.gov/pubmed/33760638
Volume 5
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6lRUK9oFa8yqOaAwdQ5JCsX-sjRK5K1BSkpqW3yvtwZdE4UWMO8IP4MfwqZtbe2KQgFS6W5dV6V55P429m58HYKyqgIoXRXpKr3AuCLPKS0Aw9yXWcRyEP_IwSnKcn0dFZMLkIL3q9n52opa-VHKjvf8wr-R-p4jOUK2XJ_oNk1y_FB3iP8sUrShivd5Jx2pRw7p8jm9Zr8mfP_BfIHqemypD9rcyqn5YrM6csqdmNMbYGA-oMVBO4HSKZ76fp7JQ8BFMbXGlc3dUr2yztmhjqpxs606naaUVJBf4LmyL3mdy5p9_my2pR14DdWP83Djz-2CZkKkIdhcQ35LmNvU-vra-vrYBgyja68Tg7L64aZ2xZZv21p-iw-LKqAw8mqOvlbSfEhI4ejrvODt6J9hoYqxR5EPtewOueMU6Dhx0N7NfdjG_9Gbhtej0efxhwCuYb1SnpHZAs5xYlPkUJRf4dRjfqdLuhLbYVC9K1J43fyHr7BJrdQdJkXuBe3nZ3ssPuu9kb1o1lObNd9qAxT-BdjbU91jPlQ_bD4QxanMEiB8QZkJyhlTM4nIHFGaBUwQEGXluUvYEGY-AwBhZjUC2gwVg7pSjBYQwIY9DB2Obaj9jZYTobH3lNfw9P8WRU0b8tjg03vopjNQqzMBHaN8io0cbOhS-1lELlSgyFjrQgR4bhaN0nidKSS634Y7Zd4kpPGWQikUh2Jfd1FGgzlMhboyAbxWgARfGQ77Mn9We9XNZFXC7dB3_215HnbKeF4At2L0etYV4iBa3kgZXuLw6IicM
link.rule.ids 786
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=External+Validation+of+the+Bone+Metastases+Ensemble+Trees+for+Survival+%28BMETS%29+Machine+Learning+Model+to+Predict+Survival+in+Patients+With+Symptomatic+Bone+Metastases&rft.jtitle=JCO+clinical+cancer+informatics&rft.au=Elledge%2C+Christen+R&rft.au=LaVigne%2C+Anna+W&rft.au=Fiksel%2C+Jacob&rft.au=Wright%2C+Jean+L&rft.date=2021-03-01&rft.eissn=2473-4276&rft.volume=5&rft.spage=304&rft_id=info:doi/10.1200%2FCCI.20.00128&rft_id=info%3Apmid%2F33760638&rft_id=info%3Apmid%2F33760638&rft.externalDocID=33760638